Glass Pharms
Articles by Glass Pharms
How Controlled Environment Farming Is Transforming Pharmaceutical Ingredient Quality
A woman scientist in protective gear inspects hydroponics lush green plants in a modern indoor garden, illuminated by vibrant pink ultraviolet and white lights. Science for food sustainable concept. IntroductionThe unwavering demand for pharmaceutical innovation hinges significantly on the quality and consistency of its raw ingredients. For pharmaceutical manufacturers, patient safety and product efficacy are paramount, making the sourcing of reliable, pure, and standardised raw materials a critical, often complex, endeavour. Traditional botanical sourcing methods frequently present a myriad of challenges, from inherent batch variability and seasonal inconsistencies to the risk of environmental contamination and unpredictable supply chains. These common...
End of Batch Growing
Our CEO was asked to speak at the World Class Business Leaders event in Frankfurt with leaders of the German Medical Cannabis markets.James explained the journey towards continuous cultivation using the latest AI, robotics and sustainable technologies to deliver consistent and clean product to market.
CIC Masterclass
James Duckenfield delivering masterclass on UK medical cannabis regulations and microbial loads Our CEO, James Duckenfield, presented on UK regulations and in particular how UK standards are significantly higher than competitors in other countries. The Cannabis Industry Council event took place at law firm Irwin Mitchell.
Opinion on UK Medical Cannabis Growth
Opinion Piece on UK Medical Cannabis The growth of UK medical cannabis has been significant, albeit slower than other comparable countries such as Germany or Australia. This opinion piece, published in the Business of Cannabis, explores the UK market growth. Read More
100th Shipment Milestone
100th Weekly Shipment Glass Pharms operates a continuous cultivation facility, allowing us to ship fresh product to customers every week. Last week, we reached a milestone with our 100th weekly shipment.
Exploring risk in the medical cannabis supply chain
Supply Chain Risk Report Glass Pharms contributed to this insightful view of supply chain risk in medical cannabis as it matures to a substantial industry. This Relm Risk Briefing: Cannabis 2026 shares learnings from that experience. It investigates how regulation, insurance, and operational practice intersect across the global supply chain, drawing on data and conversations with market leaders who are setting new standards in safety, sustainability, and accountability. Read More
Coverage on S4C
Featured on S4C Glass Pharms featured on @S4C Supporting the conversation on the future of pharmaceutical cannabis in the UK. Watch now from 06:56–09:57
Featured on BBC iPlayer
Featured as part of a documentary on cannabis in the UK Glass Pharms featured on @BBCiPlayer Supporting the conversation on the future of pharmaceutical cannabis in the UK. Watch now from 06:56–09:57